RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
RANDOMISED PHASE II TERTIARY CHEMOPREVENTION TRIAL FOR COLORECTAL ADENOMA IN 24 PATIENTS WITH COLORECTAL CANCER TREATED WITH CELECOXIB
2004-01-01 Maisano, Carmelo; Buda, Carmelo; Aragona, Marcello; Spitaleri, Gianluca; Rossello, Rosalba; Ferraro, Giuseppa; Alafaci, Elisabetta; Adamo, Vincenzo
RANDOMISED PHASE II TERTIARY CHEMOPREVENTION TRIAL FOR COLORECTAL ADENOMA IN 24 PATIENTS WITH COLORECTAL CANCER TREATED WITH CELECOXIB
2004-01-01 Maisano, C.; Buda, Carmelo; Aragona, Marcello; Spitaleri, G.; Rossello, R.; Ferraro, G.; Alafaci, E.; Adamo, Vincenzo
Re-treatment with gefitinib or treatment with erlotinib after gefitinib failure in responsive non small cell lung cancers: new strategies to overcome acquired resistance.
2013-01-01 Franchina, Tindara; Russo, A; Picciotto, Maria; Scimone, A; Berenato, R; Noto, L; Schifano, S; Adamo, Vincenzo
Results From a Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease From Italian Sites
2015-01-01 Pedrazzoli, P; Caraceni, A; Beano, A; Adamo, Vincenzo; Testore, F; Pigni, A; Body, J; Sgreccia, L; de Cock, E; Tao, S; Kritikou, P; Hechmati, G; Gatta, F.
Retrast: Retreatment after adjuvant trastuzumab—Our regional southern Italy experience.
2013-01-01 Caruso, M; Adamo, Vincenzo; Tralongo, P; Giuffrida, D; Gebbia, V; Leonardi, V; Soto Parra, Hj; Valenza, R; Borsellino, N; Sanò, Mv; Priolo, D; Di Mari, Am; Prestifilippo, A; Ricciardi, G; Miano, E; Zacchia, A; Ferraú, F.
Risk evaluation in breast cancer: a preliminary study of pre-metastatic niche in 252 lymphnodes
2009-01-01 Adamo, Vincenzo; Ieni, Antonio; Caristi, Nicola; Scarfì, R.; Barresi, Valeria; Giuffrè, G.; Gioffre', Maria; Adamo, Barbara; Colonese, Francesca; Ferraro, Giuseppa; Tuccari, Giovanni
Risk evaluation in breast cancer: a preliminary study of pre-metastatic niche in 252 negative lymphnodes.
2009-01-01 Ieni, Antonio; Simone, Angela; G., Neri; Barresi, Valeria; Giuffre', Giuseppe; Adamo, Barbara; Caristi, Nicola; Colonese, Francesca; Gioffre', Maria; Adamo, Vincenzo; Tuccari, Giovanni
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC)
2013-01-01 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Cardia, R.; Ferraro, Giuseppa; Franchina, Tindara; Picciotto, Maria; Zanghi', Mariangela; Trimarchi, Giuseppe; Tuccari, Giovanni; Adamo, Vincenzo
Role of MTHFR polymorphisms as predictive markers of acute toxicity during 5-fluorouracil based chemotherapy for colorectal cancer: Preliminary data.
2008-01-01 Adamo, Vincenzo; Franchina, Tindara; Adamo, Barbara; R., Briguglio; E., Restuccia; G., Chiofalo; Ferraro, Giuseppa; Caccamo, Daniela; R., Ientile
SAFETY AND ACTIVITY OF ERLOTINIB (TARCEVA) IN HEAVILY PRE-TREATED PATIENTS WITH METASTATIC, REFRACTORY NON SMALL CELL LUNG CANCER
2008-01-01 Franchina, Tindara; Denaro, N; Gambadauro, P; Adamo, Barbara; MAUGERI SACCA', M; Maisano, C; Scimone, A; Adamo, Vincenzo
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
RANDOMISED PHASE II TERTIARY CHEMOPREVENTION TRIAL FOR COLORECTAL ADENOMA IN 24 PATIENTS WITH COLORECTAL CANCER TREATED WITH CELECOXIB | 1-gen-2004 | Maisano, Carmelo; Buda, Carmelo; Aragona, Marcello; Spitaleri, Gianluca; Rossello, Rosalba; Ferraro, Giuseppa; Alafaci, Elisabetta; Adamo, Vincenzo | |
RANDOMISED PHASE II TERTIARY CHEMOPREVENTION TRIAL FOR COLORECTAL ADENOMA IN 24 PATIENTS WITH COLORECTAL CANCER TREATED WITH CELECOXIB | 1-gen-2004 | Maisano, C.; Buda, Carmelo; Aragona, Marcello; Spitaleri, G.; Rossello, R.; Ferraro, G.; Alafaci, E.; Adamo, Vincenzo | |
Re-treatment with gefitinib or treatment with erlotinib after gefitinib failure in responsive non small cell lung cancers: new strategies to overcome acquired resistance. | 1-gen-2013 | Franchina, Tindara; Russo, A; Picciotto, Maria; Scimone, A; Berenato, R; Noto, L; Schifano, S; Adamo, Vincenzo | |
Results From a Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease From Italian Sites | 1-gen-2015 | Pedrazzoli, P; Caraceni, A; Beano, A; Adamo, Vincenzo; Testore, F; Pigni, A; Body, J; Sgreccia, L; de Cock, E; Tao, S; Kritikou, P; Hechmati, G; Gatta, F. | |
Retrast: Retreatment after adjuvant trastuzumab—Our regional southern Italy experience. | 1-gen-2013 | Caruso, M; Adamo, Vincenzo; Tralongo, P; Giuffrida, D; Gebbia, V; Leonardi, V; Soto Parra, Hj; Valenza, R; Borsellino, N; Sanò, Mv; Priolo, D; Di Mari, Am; Prestifilippo, A; Ricciardi, G; Miano, E; Zacchia, A; Ferraú, F. | |
Risk evaluation in breast cancer: a preliminary study of pre-metastatic niche in 252 lymphnodes | 1-gen-2009 | Adamo, Vincenzo; Ieni, Antonio; Caristi, Nicola; Scarfì, R.; Barresi, Valeria; Giuffrè, G.; Gioffre', Maria; Adamo, Barbara; Colonese, Francesca; Ferraro, Giuseppa; Tuccari, Giovanni | |
Risk evaluation in breast cancer: a preliminary study of pre-metastatic niche in 252 negative lymphnodes. | 1-gen-2009 | Ieni, Antonio; Simone, Angela; G., Neri; Barresi, Valeria; Giuffre', Giuseppe; Adamo, Barbara; Caristi, Nicola; Colonese, Francesca; Gioffre', Maria; Adamo, Vincenzo; Tuccari, Giovanni | |
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) | 1-gen-2013 | Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Cardia, R.; Ferraro, Giuseppa; Franchina, Tindara; Picciotto, Maria; Zanghi', Mariangela; Trimarchi, Giuseppe; Tuccari, Giovanni; Adamo, Vincenzo | |
Role of MTHFR polymorphisms as predictive markers of acute toxicity during 5-fluorouracil based chemotherapy for colorectal cancer: Preliminary data. | 1-gen-2008 | Adamo, Vincenzo; Franchina, Tindara; Adamo, Barbara; R., Briguglio; E., Restuccia; G., Chiofalo; Ferraro, Giuseppa; Caccamo, Daniela; R., Ientile | |
SAFETY AND ACTIVITY OF ERLOTINIB (TARCEVA) IN HEAVILY PRE-TREATED PATIENTS WITH METASTATIC, REFRACTORY NON SMALL CELL LUNG CANCER | 1-gen-2008 | Franchina, Tindara; Denaro, N; Gambadauro, P; Adamo, Barbara; MAUGERI SACCA', M; Maisano, C; Scimone, A; Adamo, Vincenzo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 14.a Contributo in Rivista 76
- 14.a Contributo in Rivista::14.a.... 76
Data di pubblicazione
- 2010 - 2017 35
- 2000 - 2009 40
- 1991 - 1999 1
Editore
- Elsevier 1
Rivista
- ANNALS OF ONCOLOGY 27
- JOURNAL OF CLINICAL ONCOLOGY 20
- TUMORI 8
- PATHOLOGICA 6
- JOURNAL OF THORACIC ONCOLOGY 3
- EUROPEAN JOURNAL OF CANCER 2
- JOURNAL OF ONCOLOGY 2
- TUMORI 2
- BMC GERIATRICS 1
- CANCER RESEARCH 1
Keyword
- Breast cancer Lymph node Meta... 1
Lingua
- eng 48
Accesso al fulltext
- no fulltext 75
- restricted 1